Periodontal Medications and Their Uses

Periodontal medications play a crucial role in the management of periodontal diseases, aiding in the treatment of infections, inflammation, and tissue regeneration. Understanding the various types of medications and their specific uses is essential for effective periodontal therapy.

Types of Periodontal Medications

1. Antibiotics:

   • Uses:
     • Used to treat bacterial infections associated with periodontal disease.
     • Commonly prescribed antibiotics include amoxicillin, metronidazole, and doxycycline.
   • Mechanism:
     • They help reduce the bacterial load in periodontal pockets, promoting healing and reducing inflammation.

2. Antimicrobial Agents:

   • Chlorhexidine:
     • Uses: A topical antiseptic used as a mouth rinse to reduce plaque and gingivitis.
     • Mechanism: It disrupts bacterial cell membranes and inhibits bacterial growth.
   • Tetracycline:
     • Uses: Can be used topically in periodontal pockets to reduce bacteria.
     • Mechanism: Inhibits protein synthesis in bacteria, reducing their ability to cause infection.

3. Anti-Inflammatory Medications:

   • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs):
     • Uses: Used to manage pain and inflammation associated with periodontal disease.
     • Examples: Ibuprofen and naproxen.
   • Corticosteroids:
     • Uses: May be used in severe cases to reduce inflammation.
     • Mechanism: Suppress the immune response and reduce inflammation.

4. Local Delivery Systems:

   • Doxycycline Gel (Atridox):
     • Uses: A biodegradable gel that releases doxycycline directly into periodontal pockets.
     • Mechanism: Provides localized antibiotic therapy to reduce bacteria and inflammation.
   • Minocycline Microspheres (Arestin):
     • Uses: A localized antibiotic treatment that is placed directly into periodontal pockets.
     • Mechanism: Releases minocycline over time to combat infection.

5. Regenerative Agents:

   • Bone Grafts and Guided Tissue Regeneration (GTR) Materials:
     • Uses: Used in surgical procedures to promote the regeneration of lost periodontal tissues.
     • Mechanism: Provide a scaffold for new tissue growth and prevent the ingrowth of epithelium into the defect.

6. Desensitizing Agents:

   • Fluoride Varnishes:
     • Uses: Applied to sensitive areas to reduce sensitivity and promote remineralization.
     • Mechanism: Strengthens enamel and reduces sensitivity by occluding dentinal tubules.

Clinical Significance of Periodontal Medications

1. Management of Periodontal Disease:

   • Medications are essential in controlling infections and inflammation, which are critical for the successful treatment of periodontal diseases.

2. Adjunct to Non-Surgical Therapy:

   • Periodontal medications can enhance the effectiveness of non-surgical treatments, such as scaling and root planing, by reducing bacterial load and inflammation.

3. Surgical Interventions:

   • In surgical procedures, medications can aid in healing and regeneration, improving outcomes for patients undergoing periodontal surgery.

4. Patient Compliance:

   • Educating patients about the importance of medications in their treatment plan can improve compliance and overall treatment success.

Microbes in Periodontics

Bacteria Associated with Periodontal Health

• Primary Species:

  • Gram-Positive Facultative Bacteria:
    • Streptococcus:
      • S. sanguis
      • S. mitis
      • A. viscosus
      • A. naeslundii
    • Actinomyces:
      • Beneficial for maintaining periodontal health.

• Protective or Beneficial Bacteria:

  • Key Species:
    • S. sanguis
    • Veillonella parvula
    • Corynebacterium ochracea
  • Characteristics:
    • Found in higher numbers at inactive periodontal sites (no attachment loss).
    • Low numbers at sites with active periodontal destruction.
    • Prevent colonization of pathogenic microorganisms (e.g., S. sanguis produces peroxide).

• Clinical Relevance:

  • High levels of C. ochracea and S. sanguis are associated with greater attachment gain post-therapy.

Microbiology of Chronic Plaque-Induced Gingivitis

• Composition:

  • Roughly equal proportions of:
    • Gram-Positive: 56%
    • Gram-Negative: 44%
    • Facultative: 59%
    • Anaerobic: 41%

• Predominant Gram-Positive Species:

  • S. sanguis
  • S. mitis
  • S. intermedius
  • S. oralis
  • A. viscosus
  • A. naeslundii
  • Peptostreptococcus micros

• Predominant Gram-Negative Species:

  • Fusobacterium nucleatum
  • Porphyromonas intermedia
  • Veillonella parvula
  • Haemophilus spp.
  • Capnocytophaga spp.
  • Campylobacter spp.

• Pregnancy-Associated Gingivitis:

  • Increased levels of steroid hormones and P. intermedia.

Chronic Periodontitis

• Key Microbial Species:

  • High levels of:
    • Porphyromonas gingivalis
    • Bacteroides forsythus
    • Porphyromonas intermedia
    • Campylobacter rectus
    • Eikenella corrodens
    • Fusobacterium nucleatum
    • Actinobacillus actinomycetemcomitans
    • Peptostreptococcus micros
    • Treponema spp.
    • Eubacterium spp.

• Pathogenic Mechanisms:

  • P. gingivalis and A. actinomycetemcomitans can invade host tissue cells.
  • Viruses such as Epstein-Barr Virus-1 (EBV-1) and human cytomegalovirus (HCMV) may contribute to bone loss.

Localized Aggressive Periodontitis

• Microbiota Characteristics:
  • Predominantly gram-negative, capnophilic, and anaerobic rods.
  • Almost all localized juvenile periodontitis (LJP) sites harbor A. actinomycetemcomitans, which can comprise up to 90% of the total cultivable microbiota.

Gingivitis

Gingivitis is an inflammatory condition of the gingiva that can progress through several distinct stages. Understanding these stages is crucial for dental professionals in diagnosing and managing periodontal disease effectively. This lecture will outline the four stages of gingivitis, highlighting the key pathological changes that occur at each stage.

I. Initial Lesion

• Characteristics:
  • Increased Permeability: The microvascular bed in the gingival tissues becomes more permeable, allowing for the passage of fluids and immune cells.
  • Increased GCF Flow: There is an increase in the flow of gingival crevicular fluid (GCF), which is indicative of inflammation and immune response.
  • PMN Cell Migration: The migration of polymorphonuclear leukocytes (PMNs) is facilitated by various adhesion molecules, including:
    • Intercellular Cell Adhesion Molecule 1 (ICAM-1)
    • E-selectin (ELAM-1) in the dentogingival vasculature.
• Clinical Implications: This stage marks the beginning of the inflammatory response, where the body attempts to combat the initial bacterial insult.

II. Early Lesion

• Characteristics:

  • Leukocyte Infiltration: There is significant infiltration of leukocytes, particularly lymphocytes, into the connective tissue of the junctional epithelium.
  • Fibroblast Degeneration: Several fibroblasts within the lesion exhibit signs of degeneration, indicating tissue damage.
  • Proliferation of Basal Cells: The basal cells of the junctional and sulcular epithelium begin to proliferate, which may be a response to the inflammatory process.

• Clinical Implications: This stage represents a transition from initial inflammation to more pronounced tissue changes, with the potential for further progression if not managed.

III. Established Lesion

• Characteristics:

  • Predominance of Plasma Cells and B Lymphocytes: There is a marked increase in plasma cells and B lymphocytes, indicating a more advanced immune response.
  • Increased Collagenolytic Activity: The activity of collagen-degrading enzymes increases, leading to the breakdown of collagen fibers in the connective tissue.
  • B Cell Subclasses: The B cells present in the established lesion are predominantly of the IgG1 and IgG3 subclasses, which are important for the immune response.

• Clinical Implications: This stage is characterized by chronic inflammation, and if left untreated, it can lead to further tissue destruction and the transition to advanced lesions.

IV. Advanced Lesion

• Characteristics:

  • Loss of Connective Tissue Attachment: There is significant loss of connective tissue attachment to the teeth, which can lead to periodontal pocket formation.
  • Alveolar Bone Loss: Extensive damage occurs to the alveolar bone, contributing to the overall loss of periodontal support.
  • Extensive Damage to Collagen Fibers: The collagen fibers in the gingival tissues are extensively damaged, further compromising the structural integrity of the gingiva.
  • Predominance of Plasma Cells: Plasma cells remain predominant, indicating ongoing immune activity and inflammation.

• Clinical Implications: This stage represents the transition from gingivitis to periodontitis, where irreversible damage can occur. Early intervention is critical to prevent further progression and loss of periodontal support.

Connective Tissue of the Gingiva and Related Cellular Components

The connective tissue of the gingiva, known as the lamina propria, plays a crucial role in supporting the gingival epithelium and maintaining periodontal health. This lecture will cover the structure of the lamina propria, the types of connective tissue fibers present, the role of Langerhans cells, and the changes observed in the periodontal ligament (PDL) with aging.

Structure of the Lamina Propria

1. Layers of the Lamina Propria:

   • The lamina propria consists of two distinct layers:
     1. Papillary Layer:
        • The upper layer that interdigitates with the epithelium, containing finger-like projections that increase the surface area for exchange of nutrients and waste.
     2. Reticular Layer:
        • The deeper layer that provides structural support and contains larger blood vessels and nerves.

2. Types of Connective Tissue Fibers:

   • The lamina propria contains three main types of connective tissue fibers:

     1. Collagen Fibers:
        • Type I Collagen: Forms the bulk of the lamina propria and provides tensile strength to the gingival fibers, essential for maintaining the integrity of the gingiva.
     2. Reticular Fibers:
        • These fibers provide a supportive network within the connective tissue.
     3. Elastic Fibers:
        • Contribute to the elasticity and flexibility of the gingival tissue.

   • Type IV Collagen:

     • Found branching between the Type I collagen bundles, it is continuous with the fibers of the basement membrane and the walls of blood vessels.

Langerhans Cells

1. Description:

   • Langerhans cells are dendritic cells located among keratinocytes at all suprabasal levels of the gingival epithelium.
   • They belong to the mononuclear phagocyte system and play a critical role in immune responses.

2. Function:

   • Act as antigen-presenting cells for lymphocytes, facilitating the immune reaction.
   • Contain specific granules known as Birbeck’s granules and exhibit marked ATP activity.

3. Location:

   • Found in the oral epithelium of normal gingiva and in small amounts in the sulcular epithelium.
   • Absent from the junctional epithelium of normal gingiva.

Changes in the Periodontal Ligament (PDL) with Aging

1. Aging Effects:
   • With aging, several changes have been reported in the periodontal ligament:
     • Decreased Numbers of Fibroblasts: This reduction can lead to impaired healing and regeneration of the PDL.
     • Irregular Structure: The PDL may exhibit a more irregular structure, paralleling changes in the gingival connective tissues.
     • Decreased Organic Matrix Production: This can affect the overall health and function of the PDL.
     • Epithelial Cell Rests: There may be a decrease in the number of epithelial cell rests, which are remnants of the Hertwig's epithelial root sheath.
     • Increased Amounts of Elastic Fibers: This change may contribute to the altered mechanical properties of the PDL.

Classification of Cementum According to Schroeder

Cementum is a specialized calcified tissue that covers the roots of teeth and plays a crucial role in periodontal health. According to Schroeder, cementum can be classified into several distinct types based on its cellular composition and structural characteristics. Understanding these classifications is essential for dental professionals in diagnosing and treating periodontal conditions.

Classification of Cementum

1. Acellular Afibrillar Cementum:

   • Characteristics:
     • Contains neither cells nor collagen fibers.
     • Present in the coronal region of the tooth.
     • Thickness ranges from 1 µm to 15 µm.
   • Function:
     • This type of cementum is thought to play a role in the attachment of the gingiva to the tooth surface.

2. Acellular Extrinsic Fiber Cementum:

   • Characteristics:
     • Lacks cells but contains closely packed bundles of Sharpey’s fibers, which are collagen fibers that anchor the cementum to the periodontal ligament.
     • Typically found in the cervical third of the roots.
     • Thickness ranges from 30 µm to 230 µm.
   • Function:
     • Provides strong attachment of the periodontal ligament to the tooth, contributing to the stability of the tooth in its socket.

3. Cellular Mixed Stratified Cementum:

   • Characteristics:
     • Contains both extrinsic and intrinsic fibers and may contain cells.
     • Found in the apical third of the roots, at the apices, and in furcation areas.
     • Thickness ranges from 100 µm to 1000 µm.
   • Function:
     • This type of cementum is involved in the repair and adaptation of the tooth root, especially in response to functional demands and periodontal disease.

4. Cellular Intrinsic Fiber Cementum:

   • Characteristics:
     • Contains cells but no extrinsic collagen fibers.
     • Primarily fills resorption lacunae, which are areas where cementum has been resorbed.
   • Function:
     • Plays a role in the repair of cementum and may be involved in the response to periodontal disease.

5. Intermediate Cementum:

   • Characteristics:
     • A poorly defined zone located near the cementoenamel junction (CEJ) of certain teeth.
     • Appears to contain cellular remnants of the Hertwig's epithelial root sheath (HERS) embedded in a calcified ground substance.
   • Function:
     • Its exact role is not fully understood, but it may be involved in the transition between enamel and cementum.

Clinical Significance

• Importance of Cementum:

  • Understanding the different types of cementum is crucial for diagnosing periodontal diseases and planning treatment strategies.
  • The presence of various types of cementum can influence the response of periodontal tissues to disease and trauma.

• Cementum in Periodontal Disease:

  • Changes in the thickness and composition of cementum can occur in response to periodontal disease, affecting tooth stability and attachment.

Theories Regarding the Mineralization of Dental Calculus

Dental calculus, or tartar, is a hard deposit that forms on teeth due to the mineralization of dental plaque. Understanding the mechanisms by which plaque becomes mineralized is essential for dental professionals in managing periodontal health. The theories regarding the mineralization of calculus can be categorized into two main mechanisms: mineral precipitation and the role of seeding agents.

1. Mineral Precipitation

Mineral precipitation involves the local rise in the saturation of calcium and phosphate ions, leading to the formation of calcium phosphate salts. This process can occur through several mechanisms:

A. Rise in pH

• Mechanism: An increase in the pH of saliva can lead to the precipitation of calcium phosphate salts by lowering the precipitation constant.
• Causes:
  • Loss of Carbon Dioxide: Bacterial activity in dental plaque can lead to the loss of CO2, resulting in an increase in pH.
  • Formation of Ammonia: The degradation of proteins by plaque bacteria can produce ammonia, further elevating the pH.

B. Colloidal Proteins

• Mechanism: Colloidal proteins in saliva bind calcium and phosphate ions, maintaining a supersaturated solution with respect to calcium phosphate salts.
• Process:
  • When saliva stagnates, these colloids can settle out, disrupting the supersaturated state and leading to the precipitation of calcium phosphate salts.

C. Enzymatic Activity

• Phosphatase:
  • This enzyme, released from dental plaque, desquamated epithelial cells, or bacteria, hydrolyzes organic phosphates in saliva, increasing the concentration of free phosphate ions and promoting mineralization.
• Esterase:
  • Present in cocci, filamentous organisms, leukocytes, macrophages, and desquamated epithelial cells, esterase can hydrolyze fatty esters into free fatty acids.
  • These fatty acids can form soaps with calcium and magnesium, which are subsequently converted into less-soluble calcium phosphate salts, facilitating calcification.

2. Seeding Agents and Heterogeneous Nucleation

The second theory posits that seeding agents induce small foci of calcification that enlarge and coalesce to form a calcified mass. This concept is often referred to as the epitactic concept or heterogeneous nucleation.

A. Role of Seeding Agents

• Unknown Agents: The specific seeding agents involved in calculus formation are not fully understood, but it is believed that the intercellular matrix of plaque plays a significant role.
• Carbohydrate-Protein Complexes:
  • These complexes may initiate calcification by chelating calcium from saliva and binding it to form nuclei that promote the deposition of minerals.

Clinical Implications

1. Understanding Calculus Formation:

   • Knowledge of the mechanisms behind calculus mineralization can help dental professionals develop effective strategies for preventing and managing calculus formation.

2. Preventive Measures:

   • Maintaining good oral hygiene practices can help reduce plaque accumulation and the conditions that favor mineralization, such as stagnation of saliva and elevated pH.

3. Treatment Approaches:

   • Understanding the role of enzymes and proteins in calculus formation may lead to the development of therapeutic agents that inhibit mineralization or promote the dissolution of existing calculus.

4. Research Directions:

   • Further research into the specific seeding agents and the biochemical processes involved in calculus formation may provide new insights into preventing and treating periodontal disease.